Free Trial
NASDAQ:PROK

ProKidney (PROK) Stock Price, News & Analysis

ProKidney logo
$2.50 +0.01 (+0.40%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$2.50 0.00 (0.00%)
As of 05:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ProKidney Stock (NASDAQ:PROK)

Key Stats

Today's Range
$2.45
$2.56
50-Day Range
$0.57
$5.18
52-Week Range
$0.46
$7.13
Volume
989,584 shs
Average Volume
2.41 million shs
Market Capitalization
$735.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25
Consensus Rating
Hold

Company Overview

ProKidney Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

PROK MarketRank™: 

ProKidney scored higher than 74% of companies evaluated by MarketBeat, and ranked 263rd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ProKidney has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    ProKidney has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about ProKidney's stock forecast and price target.
  • Earnings Growth

    Earnings for ProKidney are expected to grow in the coming year, from ($0.57) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ProKidney is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ProKidney is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about ProKidney's valuation and earnings.
  • Percentage of Shares Shorted

    7.79% of the float of ProKidney has been sold short.
  • Short Interest Ratio / Days to Cover

    ProKidney has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProKidney has recently decreased by 33.65%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ProKidney does not currently pay a dividend.

  • Dividend Growth

    ProKidney does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.79% of the float of ProKidney has been sold short.
  • Short Interest Ratio / Days to Cover

    ProKidney has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProKidney has recently decreased by 33.65%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ProKidney has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for ProKidney this week, compared to 3 articles on an average week.
  • Search Interest

    Only 15 people have searched for PROK on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.
  • MarketBeat Follows

    Only 9 people have added ProKidney to their MarketBeat watchlist in the last 30 days. This is a decrease of -36% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ProKidney insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $312,510.00 in company stock.

  • Percentage Held by Insiders

    41.49% of the stock of ProKidney is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    51.59% of the stock of ProKidney is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ProKidney's insider trading history.
Receive PROK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PROK Stock News Headlines

ProKidney Reports 78 Percent Gain in Q2
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
Citi Reaffirms Their Buy Rating on ProKidney (PROK)
ProKidney Corp. (PROK) - Yahoo Finance
See More Headlines

PROK Stock Analysis - Frequently Asked Questions

ProKidney's stock was trading at $1.69 at the start of the year. Since then, PROK stock has increased by 47.9% and is now trading at $2.50.

ProKidney Corp. (NASDAQ:PROK) posted its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.01. The firm had revenue of $0.22 million for the quarter.

ProKidney's top institutional investors include JPMorgan Chase & Co. (0.57%), Geode Capital Management LLC (0.35%), Bank of America Corp DE (0.29%) and Jane Street Group LLC (0.20%). Insiders that own company stock include Control Empresarial De Capital, Pablo G Legorreta and Darin J Weber.
View institutional ownership trends
.

Shares of PROK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProKidney investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Tesla (TSLA).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PROK
CIK
1850270
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$1.00
Potential Upside/Downside
+150.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.19 million
Net Margins
N/A
Pretax Margin
-31,053.89%
Return on Equity
N/A
Return on Assets
-17.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.48
Quick Ratio
11.48

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
9,196.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.41) per share
Price / Book
-0.73

Miscellaneous

Outstanding Shares
294,280,000
Free Float
172,184,000
Market Cap
$735.70 million
Optionable
Optionable
Beta
1.76
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PROK) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners